Profiles: Page 3
The latest opinion pieces by industry thought leaders
-
DE&I Champions: Scott Gray
The CEO, founder and president of Clincierge is championing diversity and inclusion within the company and beyond.
Meagan Parrish • Sept. 6, 2022 -
Tech Wizards: Sastry Chilukuri
The co-CEO of Medidata is ushering in the next generation of clinical trial advancements, making research easier and more patient-focused than ever before.
PharmaVoice staff • Sept. 6, 2022 -
Innovators: Sarah Hersey
At Bristol Myers Squibb, Sarah Hersey challenges the norm — and herself — to continually bring the best solutions to patients as vice president of translational sciences and diagnostics.
Alexandra Pecci • Sept. 6, 2022 -
Disrupters: Samantha Singer
Abata’s CEO is stepping into the ring to fight for patients with progressive MS and other autoimmune disorders.
PharmaVoice staff • Sept. 6, 2022 -
Disrupters: Sally Allain
The newest location for Johnson & Johnson Innovation’s incubator JLABS is in Washington, D.C., and the head of the cutting-edge space is bringing a diverse set of disruptive companies together.
Michael Gibney • Sept. 6, 2022 -
Disrupters: Rosalind Brewer
The CEO of Walgreens Boots Alliance is transforming the pharmacy powerhouse into a major new player in the healthcare space.
PharmaVoice staff • Sept. 6, 2022 -
Tech Wizards: Dr. Rich Christie
Driven by an enthusiasm for invention and a connection between scientific expertise and patient outcomes, the AiCure chief medical officer looks to nurture AI-powered technology.
PharmaVoice staff • Sept. 6, 2022 -
DE&I Champions: Renata Campos
Takeda's Growth and Emerging Markets Business Unit president is driving growth by doing what’s right for patients and her teams.
PharmaVoice staff • Sept. 6, 2022 -
Legacy Leaders: Raymond Stevens
The longtime pioneer in new drug discovery methods and founder of Structure Therapeutics has leveraged innovative science for commercial success.
Meagan Parrish • Sept. 6, 2022 -
Legacy Leaders: Rahul Ballal
Imara’s CEO walks the walk when it comes to being a patient-first company by empowering his teams to lead important initiatives with far-ranging impact.
PharmaVoice staff • Sept. 6, 2022 -
Innovators: Dr. Rafael Amado
Quiet, supportive and collaborative leadership have made the R&D leader a standout innovator for Allogene Therapeutics.
Alexandra Pecci • Sept. 6, 2022 -
Legacy Leaders: Rachel Lenington
Athira Pharma’s COO is striving to transform the landscape for patients with Alzheimer’s and other neurodegenerative diseases.
PharmaVoice staff • Sept. 6, 2022 -
Entrepreneurs: Dr. Penelope Manasco
How the NIH-trained scientist and CEO of MANA RBM is charting a new way forward in conducting clinical trials.
Alexandra Pecci • Sept. 6, 2022 -
DE&I Champions: Otis Johnson
Clario’s chief diversity, inclusion and sustainability officer is looking to improve clinical trial recruitment with a bottom-up approach that first focuses on internal hiring practices.
Karissa Waddick • Sept. 6, 2022 -
Entrepreneurs: Nina Wachsman
The CEO and co-founder of Know Rare is on a mission to connect rare disease patients with researchers and clinical trials.
PharmaVoice staff • Sept. 6, 2022 -
Entrepreneurs: Nello Mainolfi
Kymera Therapeutics’ CEO is chasing untreated disease targets by advancing a game-changing technology.
PharmaVoice staff • Sept. 6, 2022 -
Tech Wizards: Nekzad Shroff
Considered one of the industry’s ‘most powerful minds,’ the VP of product management at Saama is developing digital solutions with impact.
PharmaVoice staff • Sept. 6, 2022 -
Legacy Leaders: Nancy Lurker
The CEO of EyePoint Pharmaceuticals is positioning the company to fundamentally reshape how retinal diseases are treated.
PharmaVoice staff • Sept. 6, 2022 -
Legacy Leaders: Mike Gladstone
The global president of Pfizer's Inflammation and Immunology unit is unlocking his team’s potential to meet big goals against a promising pipeline.
PharmaVoice staff • Sept. 6, 2022 -
DE&I Champions: Maureen Hennessey
The senior vice president, director of value transformation at PRECISIONvalue is moving the needle on patient nonadherence challenges.
PharmaVoice staff • Sept. 6, 2022 -
Tech Wizards: Matt Walz
The innovative CEO is driving global clinical trial enrollment with a novel approach for the industry.
Meagan Parrish • Sept. 6, 2022 -
Tech Wizards: Matt Clark
X-Chem’s CEO has pioneered DNA-encoded libraries to revolutionize small molecule discovery.
PharmaVoice staff • Sept. 6, 2022 -
DE&I Champions: Dr. Mary-Ann Etiebet
Merck’s associate vice president of health equity is making DE&I a part of the pharma giant's day-to-day strategy.
PharmaVoice staff • Sept. 6, 2022 -
DE&I Champions: Mark Sullivan
Medicines Development for Global Health’s founder is committed to eliminating neglected tropical diseases around the world.
PharmaVoice staff • Sept. 6, 2022 -
Legacy Leaders: Dr. Mark Goldberg
The savvy clinical trials pro has built a global CRO by targeting the needs of the industry’s bustling biotech sector.
PharmaVoice staff • Sept. 6, 2022